Deadline to file a claim:
01/01/2024
Proof of Purchase Required:
Yes
Potential Individual Reward:
TBD
Total Settlement Amount:
$246.75 million
Nationwide
Deadline to file a claim:
01/01/2024
Proof of Purchase Required:
Yes
Potential Individual Reward:
TBD
Total Settlement Amount:
$246.75 million
Nationwide
Deadline to file a claim:
01/01/2024
Proof of Purchase Required:
Yes
Potential Individual Reward:
TBD
Total Settlement Amount:
$246.75 million
Nationwide
Status: In progress
The class is made up of entities that purchased Truvada, Atripla or their generic equivalents directly from a brand or generic manufacturer between Feb. 1, 2018, and Sept. 27, 2022.
Deadline to file a claim:
01/01/2024
Proof of Purchase Required:
Yes
Potential Individual Reward:
TBD
Total Settlement Amount:
$246.75 million
Nationwide
Status: In progress
The deadline to submit a claim has passed.
Deadline to file a claim:
01/01/2024
Proof of Purchase Required:
Yes
Potential Individual Reward:
TBD
Total Settlement Amount:
$246.75 million
Nationwide
Status: In progress
Deadline to file a claim: 01/01/2024
Proof of Purchase Required: Yes
Potential Individual Reward: TBD
